Left atrial appendage occlusion is a generally safe and effective procedure to lower the risk of stroke in people with atrial fibrillation. It closes or blocks off the left atrial appendage of the ...
Created to address the “uncertainty and practice variation” that surrounds transcatheter left atrial appendage occlusion (LAAO), the Society for Cardiovascular Angiography and Interventions and the ...
Medtronic has secured a CE mark approval in Europe for its surgical implant to close the heart’s left atrial appendage, aimed at reducing the long-term risk of stroke that’s higher among people with ...
Hosted on MSN
Lack of benefit from left atrial appendage occlusion for some patients after valvular surgery
No benefit in terms of prevention of ischemic stroke, transient ischemic attack and cardiovascular mortality after 1 year was observed when surgical left atrial appendage occlusion was performed in ...
The 45-day post-implantation results support use of a next-generation device in people with atrial fibrillation, but caution is advised until longer-term results are available.
Please provide your email address to receive an email when new articles are posted on . OPTION is a head-to-head trial of left atrial appendage closure with Watchman FLX vs. anticoagulation after ...
SAN FRANCISCO, CA—Direct oral anticoagulants (DOACs) don’t reduce device-related thrombosis (DRT) compared with dual antiplatelet therapy (DAPT) following left atrial appendage occlusion (LAAO), but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results